Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - GENEREX BIOTECHNOLOGY CORP | ex31_2.htm |
| EX-31.1 - EXHIBIT 31.1 - GENEREX BIOTECHNOLOGY CORP | ex31_1.htm |
| 10-Q - FORM 10-Q - GENEREX BIOTECHNOLOGY CORP | gnbt043017form10q.htm |
Exhibit 32.
CERTIFICATIONS
Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. ss. 1350, as adopted), Joseph Moscato, President and Chief Executive Officer of Generex Biotechnology Corporation (the "Company"), and Mark Corrao, Chief Financial Officer of the Company, each hereby certifies that, to the best of his knowledge:
1. The Company's Quarterly Report on Form 10-Q for the period ended April 30, 2017 to which this Certification is attached as Exhibit 32 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the end of the period covered by the Report.
| Date: June 15, 2017 | By: | /s/ Joseph Moscato |
| Joseph Moscato | ||
| President & Chief Executive Officer | ||
| (Principal Executive Officer) | ||
| Date: June 15, 2017 | By: | /s/ Mark Corrao |
| Mark Corrao | ||
| Chief Financial Officer | ||
| (Principal Financial Officer) | ||